PL3344273T3 - Kompozycje zawierające magnolię, korkowiec, teaninę i/lub białko serwatkowe - Google Patents

Kompozycje zawierające magnolię, korkowiec, teaninę i/lub białko serwatkowe

Info

Publication number
PL3344273T3
PL3344273T3 PL16766152T PL16766152T PL3344273T3 PL 3344273 T3 PL3344273 T3 PL 3344273T3 PL 16766152 T PL16766152 T PL 16766152T PL 16766152 T PL16766152 T PL 16766152T PL 3344273 T3 PL3344273 T3 PL 3344273T3
Authority
PL
Poland
Prior art keywords
phellodendron
theanine
magnolia
compositions
whey protein
Prior art date
Application number
PL16766152T
Other languages
English (en)
Inventor
Todd Henderson
David Griffin
David Bledsoe
Original Assignee
Nutramax Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56926297&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3344273(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutramax Laboratories, Inc. filed Critical Nutramax Laboratories, Inc.
Publication of PL3344273T3 publication Critical patent/PL3344273T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL16766152T 2015-08-31 2016-08-31 Kompozycje zawierające magnolię, korkowiec, teaninę i/lub białko serwatkowe PL3344273T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562212080P 2015-08-31 2015-08-31
EP16766152.9A EP3344273B1 (en) 2015-08-31 2016-08-31 Compositions comprising magnolia, phellodendron, theanine and/or whey protein
PCT/US2016/049630 WO2017040611A1 (en) 2015-08-31 2016-08-31 Compositions comprising magnolia, phellodendron, theanine and/or whey protein

Publications (1)

Publication Number Publication Date
PL3344273T3 true PL3344273T3 (pl) 2020-06-01

Family

ID=56926297

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16766152T PL3344273T3 (pl) 2015-08-31 2016-08-31 Kompozycje zawierające magnolię, korkowiec, teaninę i/lub białko serwatkowe

Country Status (10)

Country Link
US (5) US10335384B2 (pl)
EP (2) EP3662919A1 (pl)
JP (4) JP6860951B2 (pl)
AU (3) AU2016317046B2 (pl)
CA (3) CA2995395C (pl)
DK (1) DK3344273T3 (pl)
ES (1) ES2775734T3 (pl)
PL (1) PL3344273T3 (pl)
PT (1) PT3344273T (pl)
WO (1) WO2017040611A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2995395C (en) 2015-08-31 2024-04-16 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein
WO2019235451A1 (ja) * 2018-06-04 2019-12-12 株式会社明治 月経随伴症状の処置のための組成物
EP4125432A4 (en) 2020-04-03 2024-04-24 Nutrition 21, LLC Method and composition for enhancing the quality and benefits of sleep
CN120240982B (zh) * 2025-04-15 2026-04-03 上海交通大学 一种基于脑电监测技术的鲜味协同作用评价方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3442073B2 (ja) 1990-08-16 2003-09-02 株式会社ヤトロン 中枢神経賦活剤
WO1999042096A1 (en) 1998-02-23 1999-08-26 Taiyo Kagaku Co., Ltd. Composition comprising theanine
EP1082306A1 (en) 1998-05-26 2001-03-14 Warner-Lambert Company Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
JP4669095B2 (ja) 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
CN100374108C (zh) 2000-04-05 2008-03-12 太阳化学株式会社 睡眠促进用组合物
JP3730522B2 (ja) 2000-07-21 2006-01-05 太陽化学株式会社 喫煙欲求抑制組成物
US6756385B2 (en) 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives
GT200100147A (es) 2000-07-31 2002-06-25 Derivados de imidazol
US6582735B2 (en) 2000-12-15 2003-06-24 Npi, Llc. Compositions and methods of use for extracts of magnoliaceae plants
UA77234C2 (en) 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
US6613362B2 (en) 2002-01-08 2003-09-02 Renew Life Formulas, Inc. Herbal formulation which acts as an intestinal bowel soother
WO2004110994A1 (en) 2003-06-18 2004-12-23 Pfizer Products Inc. Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
CA2459240C (en) * 2004-02-27 2012-10-09 Taiyo Kagaku Co., Ltd. Pharmaceutical composition for treating mood disorders
US7476406B1 (en) 2004-05-17 2009-01-13 Nse Products, Inc. Multifaceted weight control system
KR101189613B1 (ko) 2004-06-28 2012-10-10 타이요 카가꾸 가부시키가이샤 테아닌의 제조법
ITRM20050344A1 (it) 2005-06-30 2007-01-01 Luca Maria De Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
BRPI0709053A2 (pt) * 2006-03-23 2011-06-28 Herbalscience Singapore Pte Ltd extratos e métodos que compreendem espécies de chá verde
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20100021570A1 (en) 2006-06-21 2010-01-28 Harlan Clayton Bieley Smoking Cessation Treatment By Reducing Nicotine Cravings, Apetite Suppression, And Altering The Perceived Taste Of Tobacco Smoke
US8518458B2 (en) 2006-09-21 2013-08-27 Immune Guard, LLC Tea-derived compositions and methods of using same for cardiovascular health
CA2682494C (en) 2007-04-04 2011-10-11 Merck & Co., Inc. Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
ES2494849T3 (es) 2008-01-29 2014-09-16 Nakamori Pharmaceutical Co., Ltd. Composición medicinal para el tratamiento de enfermedades infecciosas respiratorias
US8652545B2 (en) 2008-02-13 2014-02-18 Reverta Health Solutions LLC Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children
KR101698216B1 (ko) * 2008-04-29 2017-01-19 디에스엠 아이피 어셋츠 비.브이. 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물
US20100003351A1 (en) * 2008-07-02 2010-01-07 Jaffe Russell M Compositions comprising rhodiola rosea and methods of use thereof
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
KR101568044B1 (ko) 2009-04-08 2015-11-10 주식회사 엘지생활건강 불안 및 스트레스 해소용 조성물
WO2011041451A2 (en) 2009-09-30 2011-04-07 Harlan Clayton Bieley Smoking cessation with body weight maintenance and nutritional supplement
WO2012071027A2 (en) 2009-11-18 2012-05-31 Solace Lifesciences, Inc. Nutraceutical based topical anxiolytic agent and method of use
CA2785056A1 (en) 2009-12-22 2011-07-21 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
US9931365B2 (en) * 2010-09-28 2018-04-03 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US8962042B2 (en) * 2010-09-28 2015-02-24 Lisa Geng Methods for treating neurological disorders using nutrient compositions
JP2012206942A (ja) * 2011-03-29 2012-10-25 Shiseido Co Ltd 皮膚萎縮改善剤
US20130064803A1 (en) 2011-09-14 2013-03-14 Naidu Lp BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH
US20150125548A1 (en) * 2011-11-14 2015-05-07 Requis Pharmaceuticals Inc. Combination nutritional and nutraceutical products
US8609162B2 (en) * 2012-10-04 2013-12-17 Invivo Beverages Llc Integrated neuromodulation system for mood enhancement of a living human subject
US20140255371A1 (en) * 2013-03-08 2014-09-11 Cognate3 Llc Physical Optimization Beverage
US20160271198A1 (en) * 2013-04-08 2016-09-22 Scientific Nutrition Products, Inc. Compositions and Methods for Promoting Sleep
JP2015137243A (ja) * 2014-01-21 2015-07-30 国立研究開発法人国立精神・神経医療研究センター 脳内アミノ酸量の調整剤
US20150320814A1 (en) 2014-05-12 2015-11-12 Creative Medical Health Inc. Nutraceutical formulation for treatment of anxiety and depression
EP3006026A1 (en) 2014-09-30 2016-04-13 Fb Health S.P.A. Pharmaceutical composition for treating anxiety containing l-theanine and baicalein
CA2995395C (en) * 2015-08-31 2024-04-16 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein

Also Published As

Publication number Publication date
PT3344273T (pt) 2020-03-03
US20190290608A1 (en) 2019-09-26
US10940130B2 (en) 2021-03-09
US20230157984A1 (en) 2023-05-25
CA3208241A1 (en) 2017-03-09
JP7537849B2 (ja) 2024-08-21
WO2017040611A1 (en) 2017-03-09
US10335384B2 (en) 2019-07-02
JP2024160292A (ja) 2024-11-13
ES2775734T3 (es) 2020-07-28
AU2016317046A1 (en) 2018-03-08
AU2022203570B2 (en) 2025-03-20
JP2023015144A (ja) 2023-01-31
EP3662919A1 (en) 2020-06-10
JP7169726B2 (ja) 2022-11-11
US20210137870A1 (en) 2021-05-13
DK3344273T3 (da) 2020-03-23
AU2022203570A1 (en) 2022-06-23
CA2995395C (en) 2024-04-16
JP6860951B2 (ja) 2021-04-21
US11752123B2 (en) 2023-09-12
EP3344273A1 (en) 2018-07-11
JP2021105012A (ja) 2021-07-26
JP2018534239A (ja) 2018-11-22
EP3344273B1 (en) 2019-12-25
CA3208235A1 (en) 2017-03-09
AU2025204496A1 (en) 2025-07-03
AU2016317046B2 (en) 2022-03-10
US20250099413A1 (en) 2025-03-27
US12194011B2 (en) 2025-01-14
CA2995395A1 (en) 2017-03-09
US20180000766A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
IL275055A (en) Tertiary antibody, method for its preparation and use
ZA201707749B (en) Compounds targeting proteins, compositions, methods, and uses thereof
SG11201802191XA (en) Makeup composition having reduced transfer, and preparation method therefor
PT3968194T (pt) Identidade digital
PT3257891T (pt) Composição magnética, revestimento que a contém e processos associados
IL275435B (en) tatk-cdkl5 fusion proteins, preparations, formulations, and their uses
PL3067375T3 (pl) Sililowane poliuretany, ich wytwarzanie i zastosowanie
GB201616657D0 (en) Methods, compositions and uses relating thereto
IL237852A0 (en) Antibodies against amphigoline, medical preparations containing them and their use
GB201715768D0 (en) Methods, compositions and uses relating thereto
GB201706349D0 (en) Methods, compositions and uses relating thereto
GB201616670D0 (en) Methods, compositions and uses relating thereto
PL3344273T3 (pl) Kompozycje zawierające magnolię, korkowiec, teaninę i/lub białko serwatkowe
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
ME03727B (me) Zamjena za so i njena primena
RO130539B8 (ro) Compoziţie erbicidă, procedeu de preparare şi utilizarea acesteia
PT3288575T (pt) Complexo de proteína-melanina bioassimilável, sua preparação e utilizações
GB201616660D0 (en) Methods, compositions and uses relating thereto
GB201616674D0 (en) Methods, compositions and uses relating thereto
ZA201708307B (en) Improved herbicidal composition, method and use
HK1246094A1 (en) Milk-based protein hydrolysates and composition made thereof
SG11201805812QA (en) Delayed-release formulations, methods of making and use thereof
GB201616645D0 (en) Methods, compositions and uses relating thereto
GB201616676D0 (en) Methods, compositions and uses relating thereto
GB201616678D0 (en) Methods, compositions and uses relating thereto